CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,353,474
- in 27 filings, $104.4M under 10b5-1 plans
Net −$104,353,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.4M Director sold 14% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −7 | $388.20 | $3K | 195,571 |
| 2026-11-02 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −295 | $400.29 | $118K | 195,276 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −9 | $388.20 | $3K | 104,733 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −410 | $400.29 | $164K | 104,323 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −200 | $405.26 | $81K | 104,123 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −432 | $406.94 | $176K | 103,691 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −408 | $408.08 | $166K | 103,283 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −520 | $409.46 | $213K | 102,763 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −120 | $410.72 | $49K | 102,643 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −120 | $411.73 | $49K | 102,523 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −120 | $412.88 | $50K | 102,403 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −80 | $414.16 | $33K | 102,323 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −760 | $415.52 | $316K | 101,563 |
| 2026-11-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −240 | $416.45 | $100K | 101,323 |
| 2026-11-02 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −7 | $388.20 | $3K | 168,214 |
| 2026-11-02 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −334 | $400.29 | $134K | 167,880 |
| 2026-11-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −21 | $387.90 | $8K | 91,211 |
| 2026-11-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −914 | $400.29 | $366K | 90,297 |
| 2026-11-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,866 | $415.64 | $1.2M | 87,431 |
| 2026-11-02 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −8 | $388.03 | $3K | 46,566 |
Page 2 of 38 · 753 trades